Skip to content

Chlormethine

Mustargen, Valchlor, Ledaga (mechlorethamine) is a small molecule pharmaceutical. Mechlorethamine was first approved as Mustargen on 1982-01-01. It is used to treat hodgkin disease, malignant pleural effusion, mycosis fungoides, and neoplasm metastasis in the USA. It has been approved in Europe to treat mycosis fungoides. Valchlor's patents are valid until 2029-07-08 (FDA).
Trade Name Ledaga
Common Name Chlormethine
Indication hodgkin disease, malignant pleural effusion, mycosis fungoides, neoplasm metastasis
Drug Class
Chlormethine
Get full access now